Search

everythinglearnresearchcommunity

for

Search:↓

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

COVID-19 can increase the risk of hair loss, especially in people over 40.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Vaccination and timely treatment reduce the risk of long COVID.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Most children with MIS-C showed significant improvement by 6 months.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Long-COVID can cause lasting symptoms, but treatment with Erbisol drugs may help.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Covid-19 worsens existing health issues and long-term effects are predictable.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.